The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases
- 18 September 2007
- journal article
- research article
- Published by Springer Nature in European Journal of Epidemiology
- Vol. 22 (12) , 839-869
- https://doi.org/10.1007/s10654-007-9165-7
Abstract
Many long-term prospective studies have reported on associations of cardiovascular diseases with circulating lipid markers and/or inflammatory markers. Studies have not, however, generally been designed to provide reliable estimates under different circumstances and to correct for within-person variability. The Emerging Risk Factors Collaboration has established a central database on over 1.1 million participants from 104 prospective population-based studies, in which subsets have information on lipid and inflammatory markers, other characteristics, as well as major cardiovascular morbidity and cause-specific mortality. Information on repeat measurements on relevant characteristics has been collected in approximately 340,000 participants to enable estimation of and correction for within-person variability. Re-analysis of individual data will yield up to approximately 69,000 incident fatal or nonfatal first ever major cardiovascular outcomes recorded during about 11.7 million person years at risk. The primary analyses will involve age-specific regression models in people without known baseline cardiovascular disease in relation to fatal or nonfatal first ever coronary heart disease outcomes. This initiative will characterize more precisely and in greater detail than has previously been possible the shape and strength of the age- and sex-specific associations of several lipid and inflammatory markers with incident coronary heart disease outcomes (and, secondarily, with other incident cardiovascular outcomes) under a wide range of circumstances. It will, therefore, help to determine to what extent such associations are independent from possible confounding factors and to what extent such markers (separately and in combination) provide incremental predictive value.Keywords
This publication has 125 references indexed in Scilit:
- Improving Prediction of Ischemic Cardiovascular Disease in the General Population Using Apolipoprotein BArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Explaining the Decline in Coronary Heart Disease Mortality in Finland between 1982 and 1997American Journal of Epidemiology, 2005
- Lipoprotein (a) and coronary heart disease among women: beyond a cholesterol carrier?European Heart Journal, 2005
- Inflammatory Markers and the Risk of Coronary Heart Disease in Men and WomenNew England Journal of Medicine, 2004
- Methodology of a two‐step quantified nutritional questionnaire and its effect on resultsNutrition and Cancer, 1998
- Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS)European Journal of Clinical Investigation, 1994
- Serum albumin, coronary heart disease, and deathAmerican Heart Journal, 1992
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989
- Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study.Circulation, 1980
- The framingham offspring study. Design and preliminary dataPreventive Medicine, 1975